Article info

Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients

Authors

  • Filière des Maladies Autoimmunes et Autoinflammatoires Rares (FAI2R); Hôpital Huriez, CHU Lille, Univ. Lille, Lille, France Google scholar articles
  1. Correspondence to FAI2R /SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium and contributors; eric.hachulla{at}chru-lille.fr
View Full Text

Citation

Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients

Publication history

  • Received June 16, 2020
  • Revised October 6, 2020
  • Accepted October 8, 2020
  • First published December 2, 2020.
Online issue publication 
March 11, 2021

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.